Brazil approves generic GLP-1 drug sold by Swiss firm Sandoz
Brazil, Canada and India are some of the first countries where the patents to GLP-1 drugs expire. Keystone-SDA…
Savings may not be enough to fund retirement beyond life expectancy: study
According to the study, around half of today’s 65-year-old women will reach the age of 90, whilst men…
The drug-pricing problem no one wants to talk about
Some pharmaceutical companies are gaming the patent system to extend their monopoly, keeping prices high for patients. Amelie-Benoist…
Psychiatry and AI: A New Era of Treatment
A scan showing areas of brain growth and loss of tissue for a patient with childhood-onset schizophrenia. AFP…
The race to launch a pill for weight loss
Researchers have continued to hunt for pills, long considered the holy grail of weight-loss medicine due to the…